BullFrog AI Holdings (BFRG) Short term Debt (2021 - 2025)
BullFrog AI Holdings' (BFRG) quarterly Short term Debt came in at $55606.0 in Q3 2025, down 67.67% on a YoY basis from $172005.0 in Q3 2024, and down 49.58% quarter-over-quarter from $110291.0 in Q2 2025.
Analysis
BullFrog AI Holdings (BFRG) Short term Debt (2021 - 2025) Analysis & Trends
BullFrog AI Holdings (BFRG) has reported Short term Debt for 5 consecutive years, with $55606.0 the latest figure, recorded in Q3 2025.
- For the quarter ending Q3 2025, Short term Debt fell 67.67% year-over-year to $55606.0; the trailing twelve-month figure through Sep 2025 stood at $55606.0 (down 67.67% YoY), and the FY2022 full-year result was $1.3 million, up 2601.82% from the prior year.
- Short term Debt eased to $55606.0 in Q3 2025 per BFRG's latest filing, from $110291.0 in the prior quarter.
- Across five years, Short term Debt topped out at $1.3 million in Q4 2022 and bottomed at $49000.0 in Q4 2021.
- Historically, Short term Debt has averaged $362625.7 across 5 years, with a median of $213290.0 in 2023.
- The sharpest annual moves came in 2022 and 2025: Short term Debt soared 2601.82% in 2022, then slumped 67.67% in 2025.
- Over 5 years, Short term Debt stood at $49000.0 in 2021, then jumped by 2601.82% to $1.3 million in 2022, then plunged by 83.89% to $213290.0 in 2023, then declined by 19.36% to $172005.0 in 2024, then plunged by 67.67% to $55606.0 in 2025.
- According to Business Quant data, Short term Debt over the past three periods registered $55606.0, $110291.0, and $164070.0 for Q3 2025, Q2 2025, and Q1 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 236.37 Bn | 222.38 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 187.38 Bn | 184.12 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 138.36 Bn | 130.51 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 85.09 Bn | 77.10 Bn | 3.93 Bn |
| 5 | Argenx Se | 63.93 Bn | 58.75 Bn | 1.37 Bn |
| 6 | Moderna | 58.07 Bn | 52.94 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 35.59 Bn | 32.28 Bn | 992.69 Mn |
| 8 | Biogen | 32.63 Bn | 31.34 Bn | 1.96 Bn |
| 9 | Insmed | 27.57 Bn | 26.41 Bn | 358.27 Mn |
| 10 | BullFrog AI Holdings | 9.27 Mn | 2.35 Mn | 106,899.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 55,606.00 |
| Jun 30, 2025 | 110,291.00 |
| Mar 31, 2025 | 164,070.00 |
| Sep 30, 2024 | 172,005.00 |
| Jun 30, 2024 | 341,040.00 |
| Mar 31, 2024 | 507,154.00 |
| Sep 30, 2023 | 213,290.00 |
| Jun 30, 2023 | 423,051.00 |
| Mar 31, 2023 | 629,486.00 |
| Dec 31, 2022 | 1.32 Mn |
| Dec 31, 2021 | 49,000.00 |